Galapagos N.V. (GLPG)
NASDAQ·Healthcare·Biotechnology
$27.75
—
Mkt Cap $2.18B
Analyst Ratings
No recent rating data.
Price Target (6 analysts)
$67.93
Range $33.00 – $97.00
Implied Upside
+144.8%
Consensus $67.93 vs current $27.75
NASDAQ·Healthcare·Biotechnology
$27.75
—
Mkt Cap $2.18B
No recent rating data.
Price Target (6 analysts)
$67.93
Range $33.00 – $97.00
+144.8%
Consensus $67.93 vs current $27.75